Radiation treatment of prostate cancer
Dr Barbara Jereczek-Fossa - European Institute of Oncology, Milan, Italy
Radiation treatment of prostate cancer ( Dr Barbara Jereczek-Fossa - European Institute of Oncology, Milan, Italy )
6 Oct 2010
Smart radiotherapy in the treatment of prostate cancer
Dr Barbara Jereczek-Fossa - European Institute of Oncology, Milan, Italy
Smart radiotherapy in the treatment of prostate cancer ( Dr Barbara Jereczek-Fossa - European Institute of Oncology, Milan, Italy )
6 Oct 2010
The use of hormone therapy to treat advanced prostate cancer
Dr Heather Payne, University College London, UK
The use of hormone therapy to treat advanced prostate cancer ( Dr Heather Payne, University College London, UK )
29 Sep 2010
Targeted therapy for bone metastases
Professor Robert Coleman, Weston Park Hospital, Sheffield, UK
Targeted therapy for bone metastases ( Professor Robert Coleman, Weston Park Hospital, Sheffield, UK )
23 Jul 2010
The role of radiotherapy in the treatment of locally advanced prostate cancer
Prof Malcolm Mason - Cardiff University, Wales
The role of radiotherapy in the treatment of locally advanced prostate cancer ( Prof Malcolm Mason - Cardiff University, Wales )
20 Jul 2010
The impact of radiotherapy on patients with high risk localised prostate cancer
Prof Wendy Parulekar - Queen's University, Canada
The impact of radiotherapy on patients with high risk localised prostate cancer ( Prof Wendy Parulekar - Queen's University, Canada )
20 Jul 2010
The efficacy of denosumab and zoledronic acid as treatment for prostate cancer
Dr Karim Fizazi - Institut Gustave Roussy, France
The efficacy of denosumab and zoledronic acid as treatment for prostate cancer ( Dr Karim Fizazi - Institut Gustave Roussy, France )
8 Jul 2010
Roundup of the 2010 ASCO conference
Prof Gordon McVie - European Institute of Oncology, Milan
Roundup of the 2010 ASCO conference ( Prof Gordon McVie - European Institute of Oncology, Milan )
11 Jun 2010
Metabolic pathway genes and bladder cancer risk
Prof Jie Lin - University of Texas M.D. Anderson Cancer Center, USA
Metabolic pathway genes and bladder cancer risk ( Prof Jie Lin - University of Texas M.D. Anderson Cancer Center, USA )
6 May 2010
BMI, plasma C-peptide and smoking levels predict prostate cancer outcome
Prof Jing Ma - Brigham and Women's Hosptial, Boston, USA
BMI, plasma C-peptide and smoking levels predict prostate cancer outcome ( Prof Jing Ma -  Brigham and Women's Hosptial, Boston, USA )
6 May 2010
Environmental tobacco smoke in relation to bladder cancer risk
Dr Li Tao - University of Minnesota, USA
Environmental tobacco smoke in relation to bladder cancer risk ( Dr Li Tao - University of Minnesota, USA )
6 May 2010
Weight gain is associated with an increased risk of prostate cancer recurrence i...
Dr Corinne Joshu - Johns Hopkins Bloomberg School of Public Health, USA
Weight gain is associated with an increased risk of prostate cancer recurrence in the PSA era ( Dr Corinne Joshu - Johns Hopkins Bloomberg School of Public Health, USA )
4 May 2010